of Ang-II and AGE (50, 100 and 150 μg/ml) were taken to check the expression of TGF-β1, vascular endothelial growth factor-A (VEGF-A) and COL4A1 for the development of in vitro DN model. This evidence concerns the gene COL4A1 and liver dysplastic nodule.